Abbott Laboratories (ABT) total assets

Total assets · fiscal 2025
$86.71B

Abbott Laboratories (ABT) had total assets of $86.71B at the end of fiscal 2025 (December 31, 2025). That is 6.5% higher than the $81.41B of fiscal 2024. Figures as of 18 Nov 2026, 05:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$86.71B
Change on fiscal 2024
+6.5%
Growth, 5 years
+3.6% a year
Growth, 10 years
+7.7% a year
Highest on record
$86.71Bfiscal 2025
Lowest on record
$39.71Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Abbott Laboratories total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 3.6% a year; over ten years the rate was 7.7% a year. Across the 19 fiscal years on record (2007–2025), the highest was $86.71B in fiscal 2025 and the lowest $39.71B in fiscal 2007.

History · 19 fiscal years

Total assets by fiscal year

Abbott Laboratories total assets, year by year

Abbott Laboratories (ABT) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$86.71B 6.5% up
2024$81.41B 11.2% up
2023$73.21B 1.6% down
2022$74.44B 1.0% down
2021$75.20B 3.6% up
2020$72.55B 6.9% up
2019$67.89B 1.1% up
2018$67.17B 11.9% down
2017$76.25B 44.8% up
2016$52.67B 27.7% up
2015$41.25B 0.1% up
2014$41.21B 4.0% down
2013$42.94B 36.1% down
2012$67.24B 11.5% up
2011$60.28B 0.5% down
2010$60.57B 15.2% up
2009$52.58B 24.0% up
2008$42.42B 6.8% up
2007$39.71B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Abbott Laboratories and comparable companies
CompanyTotal assetsFiscal year
Gilead Sciences GILD$59.02B2025
Abbott Laboratories ABT$86.71B2025
Novo Nordisk NVODKK 542.90B2025
Pfizer PFE$208.16B2025
Danaher DHR$83.46B2025
Intuitive Surgical ISRG$20.46B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABT

Abbott Laboratories, figure by figure

Abbott Laboratories (ABT) overview: price, valuation and scorecardAll health care companies by market value

Abbott Laboratories total assets: questions and answers

How large are Abbott Laboratories's total assets?

Abbott Laboratories (ABT) had total assets of $86.71B at the end of fiscal 2025 (December 31, 2025). That is 6.5% higher than the $81.41B of fiscal 2024.

What is the growth rate of Abbott Laboratories's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 3.6% a year; over ten years the rate was 7.7% a year.

What are the highest and lowest total assets figures on record for Abbott Laboratories?

Across the 19 fiscal years on record (2007–2025), the highest was $86.71B in fiscal 2025 and the lowest $39.71B in fiscal 2007.

How is Abbott Laboratories's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.